Tuesday, November 1, 2011

Professor Olav Mella: ME is a very serious and debilitating disease and Current treatment is highly unsatisfactory

Fluge replied to jvandermeer on 31 Oct 2011 at 17:47 GMT: CFS/ME according to Fukuda or Canadian criteria is in many patients a very serious and debilitating disease. Current treatment is for many patients highly unsatisfactory and we believe it is justified to find new interventions and learn more of the pathophysiology, of which we at the time being know little. The side effects of Rituximab in this particular patient group of patients is of course presently largely unknown, although there is vast experience with the drug in B-cell lymphomas and established autoimmune diseases. We believe the severity of disease in many CFS/ME patients balances the known risks. That was also the opinion of most patients who were given the option to participate in the current study at a time when only three pilot patients had been treated with the drug. Read more>>

No comments:


Related Posts with Thumbnails